The aim of our preliminary study was the assessment of the diagnostic utility of serum galectin-3 concentrations in patients with COVID-19 of various severity, in comparison to other relevant markers, including a wide panel of recommended laboratory tests, and additionally serum concentrations of PTX-3 and sFlt-1. This evidence concerns the gene PTX3 and COVID-19.